Here's why school nurses need Texas law change to give new epi nasal spray to students
This is great news, but families can't just hand over the nasal spray form to their school nurse. The Texas law allowing ...
Nasdaq3d
Milestone Pharma: FDA Issues CRL Regarding New Drug Application For CARDAMYST Nasal Spray
(RTTNews) - Milestone Pharmaceuticals (MIST) announced the FDA issued a Complete Response Letter regarding its New Drug Application for CARDAMYST nasal spray, a prescription medication in ...
Verywell Health on MSN7d
Afrin vs. Flonase: How Do They Compare for Nasal Congestion?
Afrin and Flonase are over-the-counter nasal sprays. Learn how they compare in effectiveness, side effects, and safety to ...
US FDA declines to approve Milestone's heart rhythm nasal spray; shares halve
Milestone Pharmaceuticals said on Friday the U.S. health regulator had declined to approve its nasal spray to treat a type of ...
Milestone Pharmaceuticals announces FDA issued CRL for etripamil
Milestone Pharmaceuticals (MIST) announced the U.S. Food and Drug Administration, FDA, issued a Complete Response Letter, CRL, regarding its ...
Drug Store News5d
Hikma launches cisatracurium besylate, gets OK for Kloxxado in Canada
Cisatracurium besylate injection has a market value of approximately $14 million in the 12 months ending January 2025, per ...
Hikma announces Health Canada approval of KLOXXADO® (naloxone HCl) Nasal Spray 8 mg
Hikma Pharmaceuticals PLC (Hikma, Group), the multinational generic pharmaceutical company, announces the approval of KLOXXADO ® (naloxone HCl) Nasal Spray 8 mg, by Health Canada for the treatment of ...
TMCnet3d
FDA Issues Complete Response Letter for Etripamil for PSVT
Milestone Pharmaceuticals had $69.7M in cash, cash equivalents and short-term investments as of December 31, 2024.